Urotensin II: a new pharmacologic target in the treatment of cardiovascular disease

Cardiology in Review
Nirav DesaiWilliam H Frishman

Abstract

Urotensin II was first identified over 30 years ago as a potent vasoconstrictor, and the identification of its receptor in the heart, lungs, blood vessels, and brain have made it a potential target for human pharmacotherapy. Current research would suggest that urotensin II plays a major role in the pathophysiology of various cardiovascular disease entities. This article discusses the biologic effects of urotensin under normal and pathophysiologic conditions, and reviews the research experiences with synthetic urotensin blockers in the treatment of various cardiovascular illnesses.

References

Oct 30, 1992·Biochemical and Biophysical Research Communications·J M ConlonH Vaudry
Apr 27, 1988·European Journal of Pharmacology·H ItohK Lederis
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·D PearsonH A Bern
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y CoulouarnH Vaudry
Jan 12, 1999·Cellular Signalling·T YamazakiY Yazaki
Dec 3, 1999·Biochemical and Biophysical Research Communications·Q LiuC T Caskey
Feb 26, 2000·Trends in Pharmacological Sciences·A P Davenport, J J Maguire
Apr 15, 2000·Cancer Genetics and Cytogenetics·S GeskB Schlegelberger
Aug 22, 2000·British Journal of Pharmacology·F E BottrillR White
Oct 6, 2000·European Journal of Pharmacology·O Saetrum OpgaardD N Krause
Jan 13, 2001·British Journal of Pharmacology·F D RussellD M O'Brien
Feb 13, 2001·American Journal of Physiology. Heart and Circulatory Physiology·A StirratM R MacLean
Apr 20, 2001·British Journal of Pharmacology·S M GardinerT Bennett
Jul 18, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·R A SilvestreJ Marco
Sep 21, 2001·Lancet·K TotsuneO Murakami
Jun 19, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Andre ShenoudaAdel Giaid
Jun 22, 2002·Lancet·Stephen A DouglasAdel Giaid
Sep 10, 2002·Peptides·Yang LuChao-Shu Tang
Sep 21, 2002·Lancet·A Mark RichardsTimothy G Yandle
Dec 4, 2002·Circulation·Leong L NgJoan E Davies
Dec 21, 2002·British Journal of Clinical Pharmacology·Jonathan T AffolterDavid J Webb
Jan 10, 2003·Clinical Science·Kazuhito TotsuneOsamu Murakami
Jan 25, 2003·Journal of Hypertension·Yingzi LinMitsuo Iida
Apr 25, 2003·Canadian Journal of Physiology and Pharmacology·Ghada S HassanAdel Giaid
Jun 5, 2003·American Journal of Physiology. Renal Physiology·Andrew Y ZhangAi-Ping Zou
Jun 7, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Fraser D RussellPeter Molenaar
Nov 15, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Yi Zhun ZhuEvi Kostenis
Dec 4, 2003·British Journal of Pharmacology·Riccardo PatacchiniCarlo Alberto Maggi
Mar 5, 2004·International Journal of Cardiology·Harald LappJohannes-Peter Stasch

❮ Previous
Next ❯

Citations

Feb 9, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Benjamin D HuntDavid G Lambert
Nov 13, 2012·PloS One·Elena V RomanovaJonathan V Sweedler
Dec 3, 2013·Pharmacology, Biochemistry, and Behavior·K DecaluwéJ Van de Voorde
Jun 14, 2015·Orphanet Journal of Rare Diseases·F J ProbstS R Lalani
Nov 26, 2009·Current Opinion in Lipidology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Cardiovascular Drugs and Therapy
Kwok Leung OngBernard M Y Cheung
Annals of the New York Academy of Sciences
H VaudryJérôme Leprince
Liver International : Official Journal of the International Association for the Study of the Liver
William KempStuart Roberts
Cardiovascular Revascularization Medicine : Including Molecular Interventions
Rajbabu Pakala
© 2022 Meta ULC. All rights reserved